DnB Asset Management’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q1 | – | Sell |
-8,690
| Closed | -$1.6M | – | 749 |
|
2024
Q4 | $1.6M | Buy |
8,690
+124
| +1% | +$22.9K | 0.01% | 613 |
|
2024
Q3 | $1.69M | Buy |
8,566
+183
| +2% | +$36K | 0.01% | 599 |
|
2024
Q2 | $1.73M | Buy |
8,383
+1,196
| +17% | +$247K | 0.01% | 582 |
|
2024
Q1 | $1.95M | Buy |
+7,187
| New | +$1.95M | 0.01% | 537 |
|